Ah...if you mean right now, an offer of $10bn, then it would indeed be a bit different. I thought in time, when Her-Vaxx, PD1-Vaxx, CheckVacc, etc gets a real chance to showcase their efficacy and safety, then $10bn would be way too cheap. In fact, it would be valued at far more than Afterpay at that time. That is my take. And I doubt if IMU would accept any takeover offer before they can do more with that CF33 and CD-19 products.
Ann: Imugene completes $90 M placement and launches $5 M SPP, page-375
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1854997 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 382882 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |